Designing of Trials: Power Calculations Based on Matching as a Surrogate for Randomization
Journal of Interventional Cardiology 7(6): 581-585
Article 1994 English
Authors
PJ
Peter P.T. de Jaegere
PR
Peter Ruygrok
PF
Pim J. de Feyter
Abstract
1 min read
In the design of clinical trials we strive to extract the maximum amount of information from a minimum number of patients and vet retain statistical validity. Matching has become acknowledged as a useful and valid surrogate for the randomized trial. By using data from matched trials along with power calculations we can accurately predict the number of patients required to achieve statistical significance in a related randomized trial. (J Interven Cardiol 1994; 7:581–585)
Howard I. Scher, Glenn Heller, Arturo Molina, Gerhardt Attard, Daniel C. Danila, Xiaoyu Jia, Weimin Peng, Shahneen Sandhu, David Olmos, Ruth Riisnaes, Robert G. McCormack, Tomasz Burzykowski, Thian Kheoh, Martin Fleisher, Marc Buyse, Johann S. de Bono
Atthanee Jeeyapant, Hugh W. F. Kingston, Katherine Plewes, Richard J. Maude, Josh Hanson, Michael Herdman, Stije J. Leopold, Thatsanun Ngernseng, Prakaykaew Charunwatthana, Nguyen Hoan Phu, Aniruddha Ghose, Md Mahtab Uddin Hasan, Caterina Fanello, Md Abul Faiz, Tran Tinh Hien, Nicholas Day, Sir Nicholas White, Arjen M. Dondorp
Erik Andrew, Aslam H. Anis, Mildred K. Cho, Mike Clarke, David T. Felson, Peter C Gøtzsche, Richard E. Greene, Alejandro R. Jadad, Wayne B. Jonas, Terry P. Klassen, Paul Knipschild, Andreas Laupacis, Curtis L. Meinert, David Moher, Graham Nichol, Andy Oxman, Marie-France Penman, Stuart Pocock, Joan Reisch, David L. Sackett, Kenneth F. Schulz, Judy Snider, Peter Tugwell,
Discussion(0)
No comments yet. Be the first to comment.